The AI, named CHIEF (Clinical Histopathology Imaging Evaluation Foundation), analyzes digital images of tumor tissues. It detects cancer cells, predicts the tumor’s molecular profile, and even forecasts patient survival rates. Researchers found that CHIEF is more accurate than most current AI methods, achieving nearly 94% accuracy in detecting cancer.